ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Sandoretic®:Novartis Pharma Schweiz AG
Information professionnelle complèteDDDimprimé 
Forme gal./Grpe.th.Composit.PropriétésPharm.cinét.Indic./emploiPosolog./mode d'empl.PrécautionsEffets indésir.
Interact.SurdosageRemarquesNum. SwissmedicMise à jour 
C07CA17 - Bopindolol and Other DiureticsATC-DDD Version 2016. Source: WHO
C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C07 - Beta Blocking Agents
 
C07C - Beta Blocking Agents and Other Diuretics

This group comprises combinations of beta blocking agents and diuretics excl. thiazides. Different diuretics except thiazides, may occur at each 5th level.
Combinations with other agents in addition, are classified at separate 5th levels using the 50-series.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

C07CA - Beta Blocking Agents, Non-Selective, and Other Diuretics
 
C07CA17 - Bopindolol and Other Diuretics
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home